Pertuzumab Plus High-Dose Trastuzumab in Patients With Progressive Brain Metastases and HER2-Positive Metastatic Breast Cancer: Primary Analysis of a Phase II Study

Effective therapies are needed for the treatment of patients with human epidermal growth factor receptor-2 (HER2)-positive metastatic breast cancer (MBC) with brain metastases. A trastuzumab radioisotope has been shown to localize in brain metastases of patients with HER2-positive MBC, and intracran...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Nancy U., Pegram, Mark, Sahebjam, Solmaz, Ibrahim, Nuhad, Fung, Anita, Cheng, Anna, Nicholas, Alan, Kirschbrown, Whitney, Kumthekar, Priya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2021
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376355/
https://www.ncbi.nlm.nih.gov/pubmed/33945296
http://dx.doi.org/10.1200/JCO.20.02822

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376355/
https://www.ncbi.nlm.nih.gov/pubmed/33945296
http://dx.doi.org/10.1200/JCO.20.02822

Ejemplares similares